Item 2.02 Results of Operations and Financial Condition

On November 10, 2009, the Company issued a press release announcing its financial results for the quarter ended September 30, 2009. The press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

This information and the information contained in the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. This information and the information contained in the press release attached as Exhibit 99.1 is not incorporated by reference into any filings of Corcept Therapeutics Incorporated made under the Securities Act of 1933, as amended, whether made before or after the date of the Current Report, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 7.01 Regulation FD Disclosure

On November 10, 2009, the Company issued a press release announcing its financial results for the quarter ended September 30, 2009. The press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

This information and the information contained in the press release attached as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. This information and the information contained in the press release attached as Exhibit 99.1 is not incorporated by reference into any filings of Corcept Therapeutics Incorporated made under the Securities Act of 1933, as amended, whether made before or after the date of the Current Report, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release of Corcept Therapeutics Incorporated dated November 10, 2009.

-2-

---